{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-133252","form_type":"8-K","ticker":"VNDA","cik":"0001347178","company_name":"Vanda Pharmaceuticals Inc.","filed_at":"2024-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.037572+00:00","generated_at":"2026-06-02T17:00:14.508247+00:00","sec_items":["8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Vanda receives revised unsolicited takeover proposal from Future Pak at $7.25-$7.75/share plus CVRs","bullets":["Revised proposal of $7.25-$7.75 per share in cash plus Contingent Value Rights (CVRs).","Vanda's Board will evaluate the proposal with its financial and legal advisors.","Prior proposal at same price range was rejected by Vanda.","No shareholder action required at this time."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-133252","json":"https://secwatch.observer/filing/0001193125-24-133252.json","markdown":"https://secwatch.observer/filing/0001193125-24-133252.md","text":"https://secwatch.observer/filing/0001193125-24-133252.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1347178/000119312524133252/0001193125-24-133252-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1347178/000119312524133252/d810702d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T17:00:14.508247+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}